NEWS & PRESS
Featured News
12.2021 / Press release
Eligo announces successful outcome in US CRISPR patent interference against SNIPR Biome
02.2022 / Article in Microbiome Times
ELIGO v SNIPR: a reflection on IP strategies in a competitive environment
05.2022 / Article in Biocentury
CRISPR’s other patent interference
Featured Press & Media
All News & Press
06.2022 / Press release
Eligo unlocks next generation of precision genetic medicine with foundational patents granted covering in-situ base editing of the microbiome and presents first-ever animal data at CRISPR 2022 Conference
06.2021 / Press release
Eligo Presents Preclinical Data Demonstrating for the First Time that Gut Microbiome Modulation via Delivery of CRISPR Nuclease Impacts Disease Progression
03.2021 / Press release
Eligo Bioscience strengthens leadership with the appointment of former GSK R&D Executive, Dr. Hessel, as Chief Scientific Officer
06.2020 / Press release
CARB-X funds Eligo Bioscience to develop CRISPR-based therapeutics derived from bacteriophages to kill superbugs and prevent deadly infections in transplant patients
10.2018 / Les Echos
Eligo is listed among the 10 French startups shaping the future of Healthcare